ANTI-MICROBIAL SAVIOR BIOTEQ CO., LTD Anti-Microbial Savior BioteQ Co., Ltd Share Price
Equities
6864
TW0006864002
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.9 TWD | -3.90% |
|
-3.18% | +2.17% |
| 1 week | -3.18% | ||
| Current month | -7.66% |
| 1 day | -3.90% | ||
| 1 week | -3.18% | ||
| Current month | -7.66% | ||
| 1 month | -8.96% | ||
| 3 months | -9.44% | ||
| 6 months | -1.15% | ||
| Current year | +2.17% |
1 week
25.90
27.05
1 month
25.9028.10
Current year
24.4031.20
1 year
22.5033.10
3 years
20.9570.00
5 years
20.9570.00
10 years
20.9570.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Ju Tsai
CEO | Chief Executive Officer | - | 01/04/18 |
Li Yu Hsu
DFI | Director of Finance/CFO | - | 17/02/19 |
Ying Ting Yeh
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wen Cheng Chang
BRD | Director/Board Member | - | 11/11/21 |
Fu Chun Chu
BRD | Director/Board Member | - | 11/11/21 |
Fu Kun Lin
BRD | Director/Board Member | - | 11/11/21 |
Anti Microbial Savior BioteQ Co Ltd is a Taiwan-based company mainly engaged in drug research and development. The Companyâs main products include MEDIACE (new medical dressing), which absorbs wound exudate to maintain the wound in a moist environment, promotes wound healing, and releases antibacterial ingredients to prevent wound infection; FORMOSA-1117 (antibacterial drug), which has antibacterial effects on Gram-positive bacteria and multi-drug resistant bacteria; YUAN-03 (antiviral drug) , which has antiviral effects against human coronavirus hCoV-OC43 and SARS-CoV-2.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.17% | 20.93M | |
| +54.05% | 63.85B | |
| -2.02% | 41.83B | |
| +40.01% | 40.47B | |
| -10.22% | 27.17B | |
| +13.42% | 26.52B | |
| -21.60% | 18.69B | |
| +2.89% | 12.73B | |
| +22.40% | 12.11B | |
| +27.49% | 12.07B |
- Stock Market
- Equities
- 6864 Stock
